Crockett Thomas Andrew has filed 33 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 24888 shares of KalVista Pharmaceuticals, Inc. ($KALV) on February 20, 2024.
Activity breakdown: 0 open-market purchases and 9 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 24888 | $14.11 | 211,203.0000 | 0 | 10.54% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 52,245.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6944 | $0.00 | 48,612.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Performance Stock Units | 20833 | $0.00 | 20,834.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Common Stock | 54415 | $0.00 | 236,091.0000 | 0 | 29.95% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Performance Stock Units | 20833 | $0.00 | 62,500.0000 | 0 | 25.00% | 0.00% |
| Feb. 14, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 58356 | $15.01 | 181,676.0000 | 0 | 24.31% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | A | Common Stock | 122500 | $0.00 | 240,032.0000 | 0 | 104.23% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | A | Performance Stock Units | 83333 | $0.00 | 83,333.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 9300 | $16.18 | 118,232.0000 | 0 | 7.29% | 0.00% |
| Feb. 1, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 700 | $16.81 | 117,532.0000 | 0 | 0.59% | 0.00% |
| Dec. 27, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 30000 | $12.02 | 127,532.0000 | 0 | 19.04% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Common Stock | 33583 | $0.00 | 172,339.0000 | 0 | 24.20% | 0.00% |
| Nov. 20, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 14807 | $8.23 | 157,532.0000 | 0 | 8.59% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6945 | $0.00 | 55,556.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 58,050.0000 | 0 | 9.09% | 0.00% |
| Oct. 30, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | G | Common Stock | 8000 | $0.00 | 138,756.0000 | 0 | 5.45% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6944 | $0.00 | 62,501.0000 | 0 | 10.00% | 0.00% |
| Aug. 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 14876 | $10.73 | 146,756.0000 | 0 | 9.20% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 63,855.0000 | 0 | 8.33% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Common Stock | 33582 | $0.00 | 161,632.0000 | 0 | 26.23% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Performance Stock Unit | 20833 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6944 | $0.00 | 76,390.0000 | 0 | 8.33% | 0.00% |
| Jan. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | A | Restricted Stock Unit | 83334 | $0.00 | 83,334.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Common Stock | 12750 | $0.00 | 133,677.0000 | 0 | 10.54% | 0.00% |
| May 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 5627 | $10.14 | 128,050.0000 | 0 | 4.21% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 6945 | $0.00 | 69,445.0000 | 0 | 9.09% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 69,660.0000 | 0 | 7.69% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Common Stock | 12749 | $0.00 | 127,627.0000 | 0 | 11.10% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | S | Common Stock | 6700 | $7.66 | 120,927.0000 | 0 | 5.25% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Performance Restricted Stock Unit | 6944 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Crockett Thomas Andrew | CEO | M | Restricted Stock Unit | 5805 | $0.00 | 75,465.0000 | 0 | 7.14% | 0.00% |